TP53 and cancer: Pharmacological induction of autophagy by mTOR inhibition or AMPK activation has been shown to have potential therapeutic value, and the activation of autophagy induced by mutp53 makes cancer cells more sensitive to the mTOR inhibitor everolimus, especially in cancers with p53 mutations [96].